drugset / Trial / NCT00576329

Topical 0.4% Ketorolac and Vitreoretinal Surgery

NCT00576329

Phase 2/3 Completed 76 enrolled Emory University
RandomizedSingle-groupDouble-blindPrevention

Summary

To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.

Timeline

Start
2006-11
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 0.4 % Topical

Indications

No indication recorded.